Non-q wave myocardial infarction
Also known as: Non-Q wave MI / Non-Q-wave myocardial infarction / MI / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack coronary / Myocardial infarct / Attack heart (NOS) / Infarct myocardial / Myocardial infarction / Heart attack
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06779 | Dalteparin | A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction. |
| DB08813 | Nadroparin | A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06779 | Dalteparin | Vascular endothelial growth factor A | target |
| DB06779 | Dalteparin | Heparanase | enzyme |
| DB06779 | Dalteparin | Antithrombin-III | target |
| DB06779 | Dalteparin | P-selectin | target |
| DB08813 | Nadroparin | Proto-oncogene c-Fos | target |
| DB08813 | Nadroparin | Myc proto-oncogene protein | target |
| DB08813 | Nadroparin | P-selectin | target |
| DB08813 | Nadroparin | Antithrombin-III | target |
| Drug | Drug Name | Phase | Status | Count |
|---|